{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:23:00Z","timestamp":1789150980416,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2024 Central-guided Local Science and Technology Development Fund Projects","award":["246Z7753G"],"award-info":[{"award-number":["246Z7753G"]}]},{"name":"2024 Central-guided Local Science and Technology Development Fund Projects","award":["246Z7753G"],"award-info":[{"award-number":["246Z7753G"]}]},{"name":"2024 Central-guided Local Science and Technology Development Fund Projects","award":["246Z7753G"],"award-info":[{"award-number":["246Z7753G"]}]},{"name":"2024 Central-guided Local Science and Technology Development Fund Projects","award":["246Z7753G"],"award-info":[{"award-number":["246Z7753G"]}]},{"name":"2024 Central-guided Local Science and Technology Development Fund Projects","award":["246Z7753G"],"award-info":[{"award-number":["246Z7753G"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10735-026-10786-3","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:06:27Z","timestamp":1774854387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cx43 modulates malignant phenotypes in bladder cancer cells via the c-Src\/PTEN\/FAK axis"],"prefix":"10.1007","volume":"57","author":[{"given":"Qiang","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"10786_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11010-016-2921-9","volume":"428","author":"XL Ai","year":"2017","unstructured":"Ai XL, Chi Q, Qiu Y, Li HY, Li DJ, Wang JX, Wang ZY (2017) Gap junction protein connexin43 deregulation contributes to bladder carcinogenesis via targeting MAPK pathway. Mol Cell Biochem 428:109\u2013118. https:\/\/doi.org\/10.1007\/s11010-016-2921-9","journal-title":"Mol Cell Biochem"},{"key":"10786_CR2","doi-asserted-by":"publisher","first-page":"173226","DOI":"10.1016\/j.ejphar.2020.173226","volume":"881","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh M, Zarrabi A, Samarghandian S, Najafi M (2020) PTEN: what we know of the function and regulation of this onco-suppressor factor in bladder cancer? Eur J Pharmacol 881:173226. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173226","journal-title":"Eur J Pharmacol"},{"key":"10786_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030693","author":"M Busby","year":"2018","unstructured":"Busby M, Hallett MT, Plante I (2018) The complex subtype-dependent role of connexin 43 (GJA1) in breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19030693","journal-title":"Int J Mol Sci"},{"key":"10786_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ctrv.2014.11.003","volume":"41","author":"BA Carneiro","year":"2015","unstructured":"Carneiro BA, Meeks JJ, Kuzel TM, Scaranti M, Abdulkadir SA, Giles FJ (2015) Emerging therapeutic targets in bladder cancer. Cancer Treat Rev 41:170\u2013178. https:\/\/doi.org\/10.1016\/j.ctrv.2014.11.003","journal-title":"Cancer Treat Rev"},{"key":"10786_CR5","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1097\/cm9.0000000000000455","volume":"132","author":"Q Chi","year":"2019","unstructured":"Chi Q, Wang ZY, Li HY, Song DB, Xu H, Ma G, Wang ZM, Li XM (2019) Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43. Chin Med J (Engl) 132:2354\u20132361. https:\/\/doi.org\/10.1097\/cm9.0000000000000455","journal-title":"Chin Med J (Engl)"},{"key":"10786_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41568-021-00340-6","volume":"21","author":"JC Dawson","year":"2021","unstructured":"Dawson JC, Serrels A, Stupack DG, Schlaepfer DD, Frame MC (2021) Targeting FAK in anticancer combination therapies. Nat Rev Cancer 21:313\u2013324. https:\/\/doi.org\/10.1038\/s41568-021-00340-6","journal-title":"Nat Rev Cancer"},{"key":"10786_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57080749","author":"J Dobruch","year":"2021","unstructured":"Dobruch J, Oszczud\u0142owski M (2021) Bladder cancer: current challenges and future directions. Medicina (Kaunas). https:\/\/doi.org\/10.3390\/medicina57080749","journal-title":"Medicina (Kaunas)"},{"key":"10786_CR8","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41419-021-04107-7","volume":"12","author":"C Dong","year":"2021","unstructured":"Dong C, Li X, Yang J, Yuan D, Zhou Y, Zhang Y, Shi G, Zhang R, Liu J, Fu P, Sun M (2021) PPFIBP1 induces glioma cell migration and invasion through FAK\/Src\/JNK signaling pathway. Cell Death Dis 12:827. https:\/\/doi.org\/10.1038\/s41419-021-04107-7","journal-title":"Cell Death Dis"},{"key":"10786_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA, Knowles MA, Galsky MD, Teoh J, Theodorescu D (2023) Bladder cancer. Nat Rev Dis Primers 9:58. https:\/\/doi.org\/10.1038\/s41572-023-00468-9","journal-title":"Nat Rev Dis Primers"},{"key":"10786_CR10","doi-asserted-by":"publisher","first-page":"20574","DOI":"10.1038\/srep20574","volume":"6","author":"H Egawa","year":"2016","unstructured":"Egawa H, Jingushi K, Hirono T, Ueda Y, Kitae K, Nakata W, Fujita K, Uemura M, Nonomura N, Tsujikawa K (2016) The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN. Sci Rep 6:20574. https:\/\/doi.org\/10.1038\/srep20574","journal-title":"Sci Rep"},{"key":"10786_CR11","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1158\/0008-5472.Can-22-3023","volume":"83","author":"F Exposito","year":"2023","unstructured":"Exposito F, Redrado M, Houry M, Hastings K, Molero-Abraham M, Lozano T, Solorzano JL, Sanz-Ortega J, Adradas V, Amat R, Redin E, Leon S, Legarra N, Garcia J, Serrano D, Valencia K, Robles-Oteiza C, Foggetti G, Otegui N, Felip E, Lasarte JJ, Paz-Ares L, Zugazagoitia J, Politi K, Montuenga L, Calvo A (2023) PTEN loss confers resistance to anti-PD-1 therapy in non-small cell lung cancer by increasing tumor infiltration of regulatory T cells. Cancer Res 83:2513\u20132526. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-3023","journal-title":"Cancer Res"},{"key":"10786_CR12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.molcel.2022.01.029","volume":"82","author":"X Ge","year":"2022","unstructured":"Ge X, Li M, Yin J, Shi Z, Fu Y, Zhao N, Chen H, Meng L, Li X, Hu Z, Zhao X, Guo H, Qian X (2022) Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma. Mol Cell 82:1249-1260.e7. https:\/\/doi.org\/10.1016\/j.molcel.2022.01.029","journal-title":"Mol Cell"},{"key":"10786_CR13","doi-asserted-by":"publisher","first-page":"e3178","DOI":"10.1038\/cddis.2017.367","volume":"8","author":"Q Guo","year":"2018","unstructured":"Guo Q, Lu L, Liao Y, Wang X, Zhang Y, Liu Y, Huang S, Sun H, Li Z, Zhao L (2018) Influence of c-Src on hypoxic resistance to paclitaxel in human ovarian cancer cells and reversal of FV-429. Cell Death Dis 8:e3178. https:\/\/doi.org\/10.1038\/cddis.2017.367","journal-title":"Cell Death Dis"},{"key":"10786_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4111\/icu.20240250","volume":"65","author":"JN Ho","year":"2024","unstructured":"Ho JN, Byun SS, Kim D, Ryu H, Lee S (2024) Dasatinib induces apoptosis and autophagy by suppressing the PI3K\/Akt\/mTOR pathway in bladder cancer cells. Investig Clin Urol 65:593\u2013602. https:\/\/doi.org\/10.4111\/icu.20240250","journal-title":"Investig Clin Urol"},{"key":"10786_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3892\/ijo.2019.4864","volume":"55","author":"C Hu","year":"2019","unstructured":"Hu C, Zhou H, Liu Y, Huang J, Liu W, Zhang Q, Tang Q, Sheng F, Li G, Zhang R (2019) ROCK1 promotes migration and invasion of non-small-cell lung cancer cells through the PTEN\/PI3K\/FAK pathway. Int J Oncol 55:833\u2013844. https:\/\/doi.org\/10.3892\/ijo.2019.4864","journal-title":"Int J Oncol"},{"key":"10786_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11010-012-1550-1","volume":"376","author":"YW Huang","year":"2013","unstructured":"Huang YW, Chen C, Xu MM, Li JD, Xiao J, Zhu XF (2013) Expression of c-Src and phospho-Src in epithelial ovarian carcinoma. Mol Cell Biochem 376:73\u201379. https:\/\/doi.org\/10.1007\/s11010-012-1550-1","journal-title":"Mol Cell Biochem"},{"key":"10786_CR17","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.7314\/apjcp.2014.15.7.2987","volume":"15","author":"R Ismail","year":"2014","unstructured":"Ismail R, Rashid R, Andrabi K, Parray FQ, Besina S, Shah MA, Ul Hussain M (2014) Pathological implications of Cx43 down-regulation in human colon cancer. Asian Pac J Cancer Prev 15:2987\u20132991. https:\/\/doi.org\/10.7314\/apjcp.2014.15.7.2987","journal-title":"Asian Pac J Cancer Prev"},{"key":"10786_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41419-024-07044-3","volume":"15","author":"WH Kao","year":"2024","unstructured":"Kao WH, Liao LZ, Chen YA, Lo UG, Pong RC, Hernandez E, Chen MC, Teng CJ, Wang HY, Tsai SC, Kapur P, Lai CH, Hsieh JT, Lin H (2024) SPHK1 promotes bladder cancer metastasis via PD-L2\/c-Src\/FAK signaling cascade. Cell Death Dis 15:678. https:\/\/doi.org\/10.1038\/s41419-024-07044-3","journal-title":"Cell Death Dis"},{"key":"10786_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040460","author":"JM Kazan","year":"2019","unstructured":"Kazan JM, El-Saghir J, Saliba J, Shaito A, Jalaleddine N, El-Hajjar L, Al-Ghadban S, Yehia L, Zibara K, El-Sabban M (2019) Cx43 expression correlates with breast cancer metastasis in MDA-MB-231 cells in vitro, in a mouse xenograft model and in human breast cancer tissues. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers11040460","journal-title":"Cancers (Basel)"},{"key":"10786_CR20","doi-asserted-by":"publisher","first-page":"S937","DOI":"10.4103\/0973-1482.193894","volume":"14","author":"K Li","year":"2018","unstructured":"Li K, Li GD, Sun LY, Li XQ (2018) PTEN and SHIP: impact on lymphatic metastasis in breast cancer. J Cancer Res Ther 14:S937-s941. https:\/\/doi.org\/10.4103\/0973-1482.193894","journal-title":"J Cancer Res Ther"},{"key":"10786_CR21","doi-asserted-by":"publisher","first-page":"2585743","DOI":"10.1155\/2019\/2585743","volume":"2019","author":"F Li","year":"2019","unstructured":"Li F, Zhao S, Guo T, Li J, Gu C (2019) The nutritional cytokine leptin promotes NSCLC by activating the PI3K\/AKT and MAPK\/ERK pathways in NSCLC cells in a paracrine manner. BioMed Res Int 2019:2585743. https:\/\/doi.org\/10.1155\/2019\/2585743","journal-title":"BioMed Res Int"},{"key":"10786_CR22","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/tox.24066","volume":"39","author":"Z Li","year":"2024","unstructured":"Li Z, Li Y, Liu L, Zhang C, Li X (2024) Multiple programmed cell death patterns and immune landscapes in bladder cancer: evidence based on machine learning and multi-cohorts. Environ Toxicol 39:1780\u20131801. https:\/\/doi.org\/10.1002\/tox.24066","journal-title":"Environ Toxicol"},{"key":"10786_CR23","doi-asserted-by":"publisher","first-page":"300060521103318","DOI":"10.1177\/03000605211033185","volume":"49","author":"S Liu","year":"2021","unstructured":"Liu S, Zhao Y, Liu H, Zhao X, Shen X (2021) miR-301-3p directly regulates Cx43 to mediate the development of gastric cancer. J Int Med Res 49:3000605211033185. https:\/\/doi.org\/10.1177\/03000605211033185","journal-title":"J Int Med Res"},{"key":"10786_CR24","doi-asserted-by":"publisher","first-page":"13534","DOI":"10.1080\/21655979.2022.2079252","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Dai M, Yang P, Cao L, Lu L (2022) Src-homology domain 2 containing protein tyrosine phosphatase-1 (SHP-1) directly binds to proto-oncogene tyrosine-protein kinase Src (c-Src) and promotes the transcriptional activation of connexin 43 (Cx43). Bioengineered 13:13534\u201313543. https:\/\/doi.org\/10.1080\/21655979.2022.2079252","journal-title":"Bioengineered"},{"key":"10786_CR25","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/1541-7786.Mcr-21-0199","volume":"20","author":"S McCutcheon","year":"2022","unstructured":"McCutcheon S, Spray DC (2022) Glioblastoma-astrocyte connexin 43 gap junctions promote tumor invasion. Mol Cancer Res 20:319\u2013331. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-21-0199","journal-title":"Mol Cancer Res"},{"key":"10786_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910712","author":"V Pa\u0161tar","year":"2021","unstructured":"Pa\u0161tar V, Lozi\u0107 M, Kelam N, Filipovi\u0107 N, Bernard B, Katsuyama Y, Vukojevi\u0107 K (2021) Connexin expression is altered in liver development of Yotari (dab1 -\/-) mice. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms221910712","journal-title":"Int J Mol Sci"},{"key":"10786_CR27","doi-asserted-by":"publisher","first-page":"244191","DOI":"10.3390\/cancers16244191","volume":"16","author":"S Paunikar","year":"2024","unstructured":"Paunikar S, Tamagnone L (2024) Connexin-43 in cancer: above and beyond gap junctions! Cancers (Basel) 16:244191. https:\/\/doi.org\/10.3390\/cancers16244191","journal-title":"Cancers (Basel)"},{"key":"10786_CR28","doi-asserted-by":"publisher","first-page":"103134","DOI":"10.1016\/j.ebiom.2020.103134","volume":"62","author":"SG Pelaz","year":"2020","unstructured":"Pelaz SG, Jara\u00edz-Rodr\u00edguez M, \u00c1lvarez-V\u00e1zquez A, Talaver\u00f3n R, Garc\u00eda-Vicente L, Flores-Hern\u00e1ndez R, G\u00f3mez de Cedr\u00f3n M, Tabernero M, Ram\u00edrez de Molina A, Lillo C, Medina JM, Tabernero A (2020) Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43(266\u2013283). EBioMedicine 62:103134. https:\/\/doi.org\/10.1016\/j.ebiom.2020.103134","journal-title":"EBioMedicine"},{"key":"10786_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16010032","author":"L Raji","year":"2023","unstructured":"Raji L, Tetteh A, Amin A (2023) Role of c-Src in carcinogenesis and drug resistance. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers16010032","journal-title":"Cancers (Basel)"},{"key":"10786_CR30","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3892\/ijo.2018.4263","volume":"52","author":"Y Shen","year":"2018","unstructured":"Shen Y, Li Y, Ma X, Wan Q, Jiang Z, Liu Y, Zhang D, Liu X, Wu W (2018) Connexin 43 sumoylation improves gap junction functions between liver cancer stem cells and enhances their sensitivity to HSVtk\/GCV. Int J Oncol 52:872\u2013880. https:\/\/doi.org\/10.3892\/ijo.2018.4263","journal-title":"Int J Oncol"},{"key":"10786_CR31","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.febslet.2014.01.049","volume":"588","author":"JL Solan","year":"2014","unstructured":"Solan JL, Lampe PD (2014) Specific Cx43 phosphorylation events regulate gap junction turnover in vivo. FEBS Lett 588:1423\u20131429. https:\/\/doi.org\/10.1016\/j.febslet.2014.01.049","journal-title":"FEBS Lett"},{"key":"10786_CR32","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1038\/s41388-021-01668-x","volume":"40","author":"JL Solan","year":"2021","unstructured":"Solan JL, Hingorani SR, Lampe PD (2021) Cx43 phosphorylation sites regulate pancreatic cancer metastasis. Oncogene 40:1909\u20131920. https:\/\/doi.org\/10.1038\/s41388-021-01668-x","journal-title":"Oncogene"},{"key":"10786_CR33","doi-asserted-by":"publisher","first-page":"e13404","DOI":"10.1111\/cpr.13404","volume":"56","author":"Y Su","year":"2023","unstructured":"Su Y, Wang B, Huang J, Huang M, Lin T (2023) YTHDC1 positively regulates PTEN expression and plays a critical role in cisplatin resistance of bladder cancer. Cell Prolif 56:e13404. https:\/\/doi.org\/10.1111\/cpr.13404","journal-title":"Cell Prolif"},{"key":"10786_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-03676-3","volume":"25","author":"C Tan","year":"2025","unstructured":"Tan C, Li C, Ge R, Zhang W, Wu Z, Wang S, Cui H, Wang X, Zhang L (2025) Mcl-1 downregulation enhances BCG treatment efficacy in bladder cancer by promoting macrophage polarization. Cancer Cell Int 25:48. https:\/\/doi.org\/10.1186\/s12935-025-03676-3","journal-title":"Cancer Cell Int"},{"key":"10786_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/bjc.2015.162","volume":"113","author":"A Tittarelli","year":"2015","unstructured":"Tittarelli A, Guerrero I, Tempio F, Gleisner MA, Avalos I, Sabanegh S, Ort\u00edz C, Michea L, L\u00f3pez MN, Mendoza-Naranjo A, Salazar-Onfray F (2015) Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity. Br J Cancer 113:259\u2013267. https:\/\/doi.org\/10.1038\/bjc.2015.162","journal-title":"Br J Cancer"},{"key":"10786_CR36","doi-asserted-by":"publisher","first-page":"166812","DOI":"10.1016\/j.bbadis.2023.166812","volume":"1869","author":"MZ Totland","year":"2023","unstructured":"Totland MZ, Omori Y, S\u00f8rensen V, Kryeziu K, Aasen T, Brech A, Leithe E (2023) Endocytic trafficking of connexins in cancer pathogenesis. Biochim Biophys Acta Mol Basis Dis 1869:166812. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166812","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10786_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s13104-016-2256-3","volume":"9","author":"S Vallo","year":"2016","unstructured":"Vallo S, Michaelis M, Gust KM, Black PC, Rothweiler F, Kvasnicka HM, Blaheta RA, Brandt MP, Wezel F, Haferkamp A, Cinatl J Jr. (2016) Dasatinib enhances tumor growth in gemcitabine-resistant orthotopic bladder cancer xenografts. BMC Res Notes 9:454. https:\/\/doi.org\/10.1186\/s13104-016-2256-3","journal-title":"BMC Res Notes"},{"key":"10786_CR38","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.33549\/physiolres.935187","volume":"72","author":"Z Varchulov\u00e1 Nov\u00e1kov\u00e1","year":"2023","unstructured":"Varchulov\u00e1 Nov\u00e1kov\u00e1 Z, Kuniakov\u00e1 M, \u017diaran S, Hars\u00e1nyi \u0160 (2023) Molecular biomarkers of bladder cancer: a mini-review. Physiol Res 72:S247-s256. https:\/\/doi.org\/10.33549\/physiolres.935187","journal-title":"Physiol Res"},{"key":"10786_CR39","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.21037\/tcr-22-2318","volume":"11","author":"GG Wang","year":"2022","unstructured":"Wang GG, Wang Y, Wang SL, Zhu LC (2022) Down-regulation of CX43 expression by miR-1 inhibits the proliferation and invasion of glioma cells. Transl Cancer Res 11:4126\u20134136. https:\/\/doi.org\/10.21037\/tcr-22-2318","journal-title":"Transl Cancer Res"},{"key":"10786_CR40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00345-024-04949-8","volume":"42","author":"A W\u00e9ber","year":"2024","unstructured":"W\u00e9ber A, Vignat J, Shah R, Morgan E, Laversanne M, Nagy P, Kenessey I, Znaor A (2024) Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN estimates. World J Urol 42:237. https:\/\/doi.org\/10.1007\/s00345-024-04949-8","journal-title":"World J Urol"},{"key":"10786_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/cs20160026","volume":"131","author":"HM Wise","year":"2017","unstructured":"Wise HM, Hermida MA, Leslie NR (2017) Prostate cancer, PI3K, PTEN and prognosis. Clin Sci (Lond) 131:197\u2013210. https:\/\/doi.org\/10.1042\/cs20160026","journal-title":"Clin Sci (Lond)"},{"key":"10786_CR42","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.7150\/ijbs.55453","volume":"17","author":"DP Wu","year":"2021","unstructured":"Wu DP, Zhou Y, Hou LX, Zhu XX, Yi W, Yang SM, Lin TY, Huang JL, Zhang B, Yin XX (2021) Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src\/PI3K\/Akt pathway. Int J Biol Sci 17:2380\u20132398. https:\/\/doi.org\/10.7150\/ijbs.55453","journal-title":"Int J Biol Sci"},{"key":"10786_CR43","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12885-023-10798-2","volume":"23","author":"X Yang","year":"2023","unstructured":"Yang X, Zhang S, Cui Y, Li Y, Song X, Pang J (2023) Efficacy and safety of transurethral resection of bladder tumour combined with chemotherapy and immunotherapy in bladder-sparing therapy in patients with T1 high-grade or T2 bladder cancer: a protocol for a randomized controlled trial. BMC Cancer 23:320. https:\/\/doi.org\/10.1186\/s12885-023-10798-2","journal-title":"BMC Cancer"},{"key":"10786_CR44","doi-asserted-by":"publisher","first-page":"1346971","DOI":"10.3389\/fphys.2024.1346971","volume":"15","author":"SS Yasarbas","year":"2024","unstructured":"Yasarbas SS, Inal E, Yildirim MA, Dubrac S, Lamartine J, Mese G (2024) Connexins in epidermal health and diseases: insights into their mutations, implications, and therapeutic solutions. Front Physiol 15:1346971. https:\/\/doi.org\/10.3389\/fphys.2024.1346971","journal-title":"Front Physiol"},{"key":"10786_CR45","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cellsig.2014.01.025","volume":"26","author":"LL Zhang","year":"2014","unstructured":"Zhang LL, Liu J, Lei S, Zhang J, Zhou W, Yu HG (2014) PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression. Cell Signal 26:1011\u20131020. https:\/\/doi.org\/10.1016\/j.cellsig.2014.01.025","journal-title":"Cell Signal"},{"key":"10786_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12964-022-01009-9","volume":"21","author":"M Zhou","year":"2023","unstructured":"Zhou M, Zheng M, Zhou X, Tian S, Yang X, Ning Y, Li Y, Zhang S (2023) The roles of connexins and gap junctions in the progression of cancer. Cell Commun Signal 21:8. https:\/\/doi.org\/10.1186\/s12964-022-01009-9","journal-title":"Cell Commun Signal"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10786-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10786-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10786-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:56:18Z","timestamp":1777366578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10786-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10786"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10786-3","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"26 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Affiliated Hospital of Chengde Medical University\n                      .\n                      Animal studies were performed in compliance with the ARRIVE guidelines. (CYFYLL2024368).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"129"}}